We treat cancer with alternative, conventional, & naturopathic methods.

Devic’s disease (neuromyelitis optica)

Devic's disease, also known as neuromyelitis optica (NMO), is a rare and serious autoimmune disorder that primarily affects the optic nerves (causing vision problems) and the spinal cord (causing paralysis and other neurological symptoms). NMO is characterized by episodes of severe inflammation that damage these areas of the central nervous system (CNS).

Devic's disease, also known as neuromyelitis optica (NMO), is a rare and serious autoimmune disorder that primarily affects the optic nerves (causing vision problems) and the spinal cord (causing paralysis and other neurological symptoms). NMO is characterized by episodes of severe inflammation that damage these areas of the central nervous system (CNS).

Key Features of Devic's Disease (Neuromyelitis Optica):

  1. Symptoms:
    • Optic neuritis: This is one of the hallmark features of NMO. It causes painful loss of vision or blurry vision in one or both eyes, often with associated pain behind the eyes, which worsens with eye movement.
    • Transverse myelitis: This is inflammation of the spinal cord, leading to weakness or paralysis, particularly in the legs, as well as numbness, tingling, or loss of sensation in the limbs. People may also experience bladder and bowel dysfunction, such as difficulty urinating or incontinence.
    • Motor and sensory deficits: Weakness in the muscles, difficulty walking, and abnormal sensations can occur due to spinal cord involvement.
    • Pain: Some individuals may experience severe pain, particularly along the back or limbs, due to spinal cord inflammation.
    • Other symptoms: In some cases, there may be nausea, vomiting, fatigue, or fever during flare-ups.
  2. Causes and Risk Factors:NMO is considered an autoimmune disorder, where the body's immune system mistakenly attacks its own tissues—in this case, the myelin (the protective covering of nerve fibers) in the optic nerves and spinal cord.
    • Aquaporin-4 antibodies: Most individuals with NMO have elevated levels of anti-aquaporin-4 antibodies (AQP4-IgG). These antibodies target a protein called aquaporin-4, which is involved in the function of astrocytes (cells that support nerve function) in the CNS. The destruction of aquaporin-4 leads to inflammation and damage.
    • Genetic factors: While the exact cause of NMO is unknown, some genetic factors may make individuals more susceptible to developing the disease, particularly in those with a family history of autoimmune conditions.
    • Infections or environmental factors: Certain infections, like viral infections, may trigger or exacerbate the condition in genetically predisposed individuals.
  3. Diagnosis:Diagnosing NMO can be challenging because its symptoms often overlap with other conditions, such as multiple sclerosis (MS). However, several diagnostic tools help to confirm the diagnosis:
    • Blood tests: The presence of anti-aquaporin-4 antibodies is a key diagnostic marker for NMO, though not all patients with the disease will test positive.
    • MRI (Magnetic Resonance Imaging): MRI scans are used to identify lesions in the optic nerves and spinal cord that are typical of NMO. These lesions are often large and extend across multiple vertebrae in the spinal cord.
    • Spinal fluid analysis: Cerebrospinal fluid (CSF) obtained via a lumbar puncture may show increased white blood cells and proteins indicative of inflammation, although this is not always specific to NMO.
    • Visual evoked potentials: This test measures the electrical activity of the brain in response to visual stimuli and can help detect damage to the optic nerves.
  4. Treatment:There is currently no cure for Devic's disease, but treatments aim to reduce inflammation, manage symptoms, and prevent further attacks:
    • Acute treatment:
      • Corticosteroids (e.g., methylprednisolone) are often given in high doses during acute attacks to reduce inflammation and help manage symptoms.
      • Plasma exchange (plasmapheresis) may be used for severe attacks that do not respond to steroids. It helps remove harmful antibodies from the blood.
    • Long-term treatment: After an acute attack, immunosuppressive medications are used to reduce the frequency and severity of relapses. These may include:
      • Azathioprine
      • Mycophenolate mofetil
      • Rituximab (a monoclonal antibody that targets immune cells responsible for the damage).
      • Mitoxantrone or interferon-beta may sometimes be used, though they are more common in treating conditions like multiple sclerosis.
    • Symptomatic treatment: Medications may be prescribed to manage specific symptoms such as pain, spasticity, and bladder dysfunction.
  5. Prognosis:The prognosis for individuals with NMO can vary greatly. Some people may experience frequent attacks that cause significant disability, while others may have fewer relapses and better long-term outcomes. Early diagnosis and effective treatment are crucial in improving outcomes and reducing disability.
    • Relapses: NMO tends to be a relapsing-remitting condition, meaning patients experience periods of worsening symptoms (attacks) followed by periods of remission.
    • Disability: If untreated or poorly managed, NMO can lead to significant disability, including vision loss and paralysis. However, with early and aggressive treatment, the severity and frequency of attacks can be reduced, and some individuals can maintain a relatively normal quality of life.
  6. Complications:
    • Permanent vision loss: Damage to the optic nerves can lead to partial or complete blindness in one or both eyes.
    • Spinal cord damage: Severe and repeated attacks can cause permanent weakness, loss of sensation, and paralysis, particularly in the legs.
    • Bladder and bowel issues: NMO can lead to incontinence or difficulty controlling urination and bowel movements.